-
EP0463596
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0463596
| EP0463596 - Cerebral function enhancing pyrimidinyl derivatives [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 09.06.1995 Database last updated on 09.05.2025 | Most recent event Tooltip | 09.06.1995 | Application deemed to be withdrawn | published on 02.08.1995 [1995/31] | Applicant(s) | For all designated states Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, NJ 08543 / US | [N/P] |
| Former [1992/01] | For all designated states Bristol-Myers Squibb Company 345 Park Avenue New York, N.Y. 10154 / US | Inventor(s) | 01 /
Mattson, Ronald J. 65 Smithfield Avenue Meriden, CT 06450 / US | 02 /
Mayol, Robert 56 Green Lane Durham, CT 06244 / US | 03 /
Brady, Michael E. 3218 Far Reach Drive Baldwinsville, NY 13027 / US | [1992/01] | Representative(s) | Kinzebach, Werner, et al Reitstötter, Kinzebach & Partner Patentanwälte Postfach 86 06 49 81633 München / DE | [N/P] |
| Former [1992/01] | Kinzebach, Werner, Dr., et al Patentanwälte Reitstötter, Kinzebach und Partner Postfach 86 06 49 D-81633 München / DE | Application number, filing date | 91110373.7 | 24.06.1991 | [1992/01] | Priority number, date | US19900544570 | 27.06.1990 Original published format: US 544570 | [1992/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP0463596 | Date: | 02.01.1992 | Language: | EN | [1992/01] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 12.09.1991 | Classification | IPC: | C07D401/14, A61K31/505 | [1992/01] | CPC: |
C07D401/14 (EP,KR,US);
A61P25/28 (EP)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, NL, SE [1992/01] | Title | German: | Cerebrale Funktion verbessernde Pyrimidinylderivate | [1992/01] | English: | Cerebral function enhancing pyrimidinyl derivatives | [1992/01] | French: | Dérivés pyrimidinyliques activant la fonction cérébrale | [1992/01] | File destroyed: | 03.03.2001 | Examination procedure | 30.06.1992 | Examination requested [1992/35] | 22.09.1994 | Despatch of a communication from the examining division (Time limit: M04) | 03.02.1995 | Application deemed to be withdrawn, date of legal effect [1995/31] | 07.03.1995 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [1995/31] | Fees paid | Renewal fee | 14.06.1993 | Renewal fee patent year 03 | 11.06.1994 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [AP]US4524206 (NEW JAMES S [US], et al); | [A]FR2584408 (BRISTOL MYERS CO [US]); | [AP]US4963678 (MADDING GARY D [US], et al) |